feed rss
decorazione
Star Alliance

IWG CME 2.2

IWG (Immunonephrology Working Group)

 

ROOM BEYAZIT
11.30 - 13.00



Treatment of Lupus Nephritis


Chairs: David Jayne, Cambridge, UK
            Vladimir Tesar, Prague, Czech Republic


- Rituximab (in the treatment of lupus nephritis): do the benefits outweight the risks?
Vladimir Tesar, Prague, Czech Republic

- Rituximab associated with mycophenolate: the LUNAR trial experience
Fernando Fervenza, Rochester, USA

- Update on biologic and stem cell therapies for lupus nephritis
David Jayne, Cambridge, UK

- The role of repeated biopsies in the management of Lupus Nephritis
Franco Ferrario, Milan, Italy


In order to participate in the CME Courses held on May 18, 2013, all regularly registered congress members must go to the session halls and have their badge scanned by the hostesses at the entrance (at participant’s own responsibility). Please note that the seat capacity of the conference rooms is limited, therefore participation in these courses will be on a “first come first served” basis. The courses are reserved to regularly registered congress members and are included in the registration fee.

 
back to the timetable



final programme "day by day" - may 18 - 21, 2013

today